| AGEs | advanced glycation end products |
| AGIs | α-glucosidase inhibitors |
| AMPK | adenosine monophosphate-activated protein kinase |
| AUC | area under the curve |
| CAT | catalase |
| C/EBP (α/δ) | CCAAT/enhancer-binding protein (alpha/delta) |
| CYP2E1 | cytochrome P450 2E1 |
| DHEA | dehydroepiandrosterone |
| FAS | fatty acid synthase |
| GLUT (1/4) | glucose transporter (1/4) |
| GPx | glutathione peroxidase |
| HFD | high-fat diet |
| HO-1 | heme oxygenase-1 |
| HOMA-IR | homeostatic model assessment of insulin resistance |
| iNOS | induced nitric oxide synthase |
| IL (1β/6/10) | interleukin (1β/6/10) |
| IR | insulin resistance |
| IRS (1/2) | insulin receptor substrate (1/2) |
| LDL | low-density lipoprotein |
| LPL | lipoprotein lipase |
| MAPK | mitogen-activated protein kinase |
| MDA | malondialdehyde |
| MGO | methylglyoxal |
| mRNA | messenger ribonucleic acid |
| NFκB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | nitric oxide |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| OGTT | oral glucose tolerance test |
| PAI-1 | plasminogen activator inhibitor-1 |
| PCOS | polycystic ovary syndrome |
| PI3K | phosphatidylinositol 3-kinase |
| PKB (=Akt) | protein kinase B |
| PPAR-γ | peroxisome proliferator-activated receptor gamma |
| PTP1B | protein tyrosine phosphatase-1B |
| ROS | reactive oxygen species |
| RXR | retinoid X receptor |
| SOD | superoxide dismutase |
| STZ | streptozotocin |
| T1DM | type 1 diabetes mellitus |
| TC | total cholesterol |
| TG | triglycerides |
| TGF-β | transforming growth factor β |
| TNF-α | tumor necrosis factor α |
| VEGF | vascular endothelial growth factor |